This article is from the source 'bbc' and was first published or seen on . It will not be checked again for changes.
You can find the current article at its original source at http://news.bbc.co.uk/go/rss/-/1/hi/england/london/7288326.stm
The article has changed 2 times. There is an RSS feed of changes available.
Previous version
1
Next version
Version 0 | Version 1 |
---|---|
Woman 'denied sight-save drugs' | Woman 'denied sight-save drugs' |
(about 4 hours later) | |
A grandmother has said she will go blind unless she can persuade her local NHS to fund drug treatment. | A grandmother has said she will go blind unless she can persuade her local NHS to fund drug treatment. |
Margaret Coates, 79, from Bromley, south-east London, has wet age-related macular degeneration (AMD), which can lead to blindness in both eyes. | Margaret Coates, 79, from Bromley, south-east London, has wet age-related macular degeneration (AMD), which can lead to blindness in both eyes. |
Her local Primary Care Trust (PCT) will not pay for a drug called Lucentis, Mrs Coates said. | Her local Primary Care Trust (PCT) will not pay for a drug called Lucentis, Mrs Coates said. |
Bromley PCT said patients who did not meet London-wide treatment criteria could apply for exceptional treatment. | Bromley PCT said patients who did not meet London-wide treatment criteria could apply for exceptional treatment. |
Wet AMD, which affects the central part of the retina, is the leading cause of sight loss in the UK, affecting around a quarter of a million people. | Wet AMD, which affects the central part of the retina, is the leading cause of sight loss in the UK, affecting around a quarter of a million people. |
The thought of going blind terrifies me Margaret Coates | The thought of going blind terrifies me Margaret Coates |
Last year the National Institute for Health and Clinical Excellence recommended that NHS patients with wet AMD should be eligible for sight-saving drug Lucentis. | Last year the National Institute for Health and Clinical Excellence recommended that NHS patients with wet AMD should be eligible for sight-saving drug Lucentis. |
But the availability of the treatment, which can cost thousands of pounds, varies between PCTs. | But the availability of the treatment, which can cost thousands of pounds, varies between PCTs. |
Mrs Coates, 79, said: "I can't believe the PCT is abandoning me like this when I could lose my sight. | Mrs Coates, 79, said: "I can't believe the PCT is abandoning me like this when I could lose my sight. |
"The thought of going blind terrifies me" | "The thought of going blind terrifies me" |
The Royal National Institute of Blind People (RNIB) and the Macular Disease Society (MDS) are campaigning for Bromley PCT to reverse its decision and fund the treatment. | The Royal National Institute of Blind People (RNIB) and the Macular Disease Society (MDS) are campaigning for Bromley PCT to reverse its decision and fund the treatment. |
'Unique factor' | 'Unique factor' |
Bromley PCT said it funds Lucentis treatment for Bromley residents with AMD in line with criteria agreed for the whole of south-east London. | Bromley PCT said it funds Lucentis treatment for Bromley residents with AMD in line with criteria agreed for the whole of south-east London. |
"Patients who do not meet these criteria can apply through their clinician to the PCT's exceptional treatments group," a spokesman said. | "Patients who do not meet these criteria can apply through their clinician to the PCT's exceptional treatments group," a spokesman said. |
In order to qualify there must be an "unusual or unique clinical factor" that differentiates the patient from others with the condition, he said. | In order to qualify there must be an "unusual or unique clinical factor" that differentiates the patient from others with the condition, he said. |
Last month former Second World War pilot Jack Tagg, 88, from Torquay, Devon, won his own battle for NHS treatment for AMD. | |
Torbay Care Trust offered to pay for his treatment because there had been a technical error over the decision appeals procedure. | Torbay Care Trust offered to pay for his treatment because there had been a technical error over the decision appeals procedure. |
Previous version
1
Next version